• Latest Posts

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

Biotech of the week: Genenta Biosciences, a Novel Gene Therapies from Italy

First-ever in utero Stem Cell Trial to be conducted by Karolinska Institutet

Why can’t Novartis Commit to the Israeli Biotech Scene?

Biotech of the week: Cell2b, the Promising Portuguese Cell Therapy Biotech

Francis Crick Institute pushes to do human embryo research

ADVERTISEMENT

Milestone in Stem Cell Research: European Researchers grow Millimeter-Long Muscle Fibers!

Researchers found the missing key factor to unleash the potential of iPS Cells

ReNeuron backed by First-Class Investor Woodford to advance Stem Cell Therapy

Novartis declines Gamida’s buyout deal for the second time

Interview with CELLPROTHERA, the regenerative medicine pioneer

Important Bilateral Academic Agreement for the Future of iPS Cell Therapy

ADVERTISEMENT